Cardiovascular disorders in patients with Zika Virus: integrative review

Main Article Content

Lucas Dalvi Armond Rezende
https://orcid.org/0000-0002-3313-852X
Paula de Souza Silva Freitas
Davi de Souza Catabriga
https://orcid.org/0000-0003-2937-9731
Helaine Jacinta Salvador Mocelin
https://orcid.org/0000-0001-9789-9670
Kelly Eduarda de Jesus Silva
https://orcid.org/0000-0003-2539-1207
Lavinya Moreira Silva
Bruno Henrique Fiorin
https://orcid.org/0000-0002-1629-9233

Abstract

Objective: To describe the primary cardiovascular disorders manifested in patients infected with the zika virus and understand the pathophysiological process. Methods: This integrative literature review occurred in January 2021 through the PICO strategy, which answered the guiding question: “What are the main cardiovascular disorders manifested in patients infected with zika virus?” For this, a time interval of 5 years was defined, using the descriptors “Zika Virus”,“Heart” and “Cardiovascular Diseases” in English, Portuguese and Spanish. The contemplated databases were MEDLINE, LILACS, and BDENF. Results: There were a total of 77,872 articles, of which, after the exclusion and inclusion processes, it was summarized in eight articles included in this review. The main cardiovascular findings present were apical muscular ventricular septal defect and ostium secundum, in addition to atrial fibrillation and heart failure with reduced ejection fraction. Conclusions: Further studies with more robustness that clearly establish the mechanism of cellular tropism for cardiac muscle cells and involve the pathophysiological process of cardiac alterations more clearly and reliably are needed.



Article Details

How to Cite
1.
Rezende LDA, Freitas P de SS, Catabriga D de S, Mocelin HJS, de Jesus Silva KE, Moreira Silva L, Fiorin BH. Cardiovascular disorders in patients with Zika Virus: integrative review. Health Sci J [Internet]. 2022Mar.29 [cited 2024Apr.20];12(1):47-3. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1210
Section
ORIGINAL ARTICLE
Author Biographies

Lucas Dalvi Armond Rezende, Federal University of Espirito Santo

Nursing Student at the Federal University of Espírito Santo. Vice President of the Integrated Academic League of Cardiology (LAICard) and President of the Integrated Academic League of Pharmacology (LAIF).

Paula de Souza Silva Freitas, Federal University of Espírito Santo

PhD in Public Health by the Postgraduate Program in Public Health (PPGSC) at the Federal University of Espírito Santo. Professor at the Nursing Department and at the PPGEnf.

Davi de Souza Catabriga, Higher School of Sciences of the Santa Casa de Misericórdia de Vitória

Medical Student at the Higher School of Sciences of Santa Casa de Misericórdia de Vitória (EMESCAM). Director of the Espírito Santo Organ and Tissue Transplant League (LITOTES).

Helaine Jacinta Salvador Mocelin, Federal University of Espirito Santo

Master's and Doctoral Student in Public Health by the Postgraduate Program in Public Health (PPGSC-UFES). Nurse in the Maternal and Child area.

Kelly Eduarda de Jesus Silva, Federal University of Espírito Santo

Nursing Student from the Federal University of Espírito Santo. Director of Research and Extension of the Integrated Academic League of Cardiology (LAICard).

Lavinya Moreira Silva, Federal University of Espírito Santo

Nursing Student from the Federal University of Espírito Santo. Marketing and Communications Director of the Integrated Academic League of Cardiology (LAICard).

Bruno Henrique Fiorin, Federal University of Espirito Santo

Nurse. Master in Public Health by the Postgraduate Program in Public Health (PPGSC-UFES). Doctor in Medicine, Cardiology, Federal University of São Paulo (UNIFESP).

References

1. Wikan N, Smith DR. Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis. 2016;16(7):e119-26. https://doi.org/10.1016/S1473-3099(16)30010-X
2. Kuno G, Chang GJ. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007;152(4):687-96. https://doi.org/10.1007/s00705-006-0903-z
3. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321-34. https://doi.org/10.1056/NEJMoa1602412
4. Gordon-Lipkin E, Peacock G. The spectrum of developmental disability with Zika exposure: what is known, what is unknown, and implications for clinicians. J Dev Behav Pediatr. 2019;40(5):387-95. https://doi.org/10.1097/DBP.0000000000000665
5. Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531-9. https://doi.org/10.1016/S0140-6736(16)00562-6
6. Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Fonseca EB, et al. Characterizing the pattern of anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr. 2017;171(3):288-95. https://doi.org/10.1001/jamapediatrics.2016.3982
7. Minhas AM, Nayab A, Iyer S, Narmeen M, Fatima K, Khan MS, et al. Association of Zika Virus with myocarditis, heart failure, and arrhythmias: a literature review. Cureus. 2017;9(6):e1399. https://doi.org/10.7759/cureus.1399
8. Orofino DH, Passos SR, de Oliveira RV, Farias CV, Leite MF, Pone SM, et al. Cardiac findings in infants with in utero exposure to Zika virus- a cross sectional study. PLoS Negl Trop Dis. 2018;12(3):e0006362. https://doi.org/10.1371/journal.pntd.0006362
9. Carta KG, Britto IJ, Meza Y, Morr I, Marques J, Flores VF, et al. Sex and gender differences in Zika myocarditis. J Am Coll Cardiol. 2019;73(9 Supp 1):719. https://doi.org/10.1016/S0735-1097(19)31327-0
10. Botelho LL, Cunha CC, Macedo M. O Método da revisão integrativa nos estudos organizacionais. Gestão e Sociedade. 2011;5(11):121-36. https://doi.org/10.21171/ges.v5i11.1220
11. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018,169(7):467-73. https://doi.org/10.7326/M18-0850
12. Brugnolli A, Cavada L, Saiani L. II sistema GRADE. Vol. 33, Assistenza Infermieristica e Ricerca. 2014. 924-926 p.
13. Abdalla LF, Santos JH, Barreto RT, Souza EM, D'Assunção FF, Borges MA, et al. Atrial fibrillation in a patient with Zika virus infection. Virol J. 2018;15:23. https://doi.org/10.1186/s12985-018-0938-2
14. Angelidou A, Michael Z, Hotz A, Friedman K, Emani S, LaRovere K, et al. Is there more to Zika? Complex cardiac disease in a case of Congenital Zika Syndrome. Neonatol. 2018;113(2):177-82. https://doi.org/10.1159/000484656
15. Cavalcanti DD, Alves LV, Furtado GJ, Santos CC, Feitosa FG, Ribeiro MC, et al. Echocardiographic findings in infants with presumed congenital Zika syndrome: Retrospective case series study. PLoS One. 2017;12(4):e0175065. https://doi.org/10.1371/journal.pone.0175065
16. Orofino DH, Passos SR, Pone SM, Pone MV, Aguiar EB, Araújo IO, et al. 24-hour Holter findings in infants with in-utero exposure to the Zika virus: a series of cases. Rev Inst Med Trop São Paulo. 2020;62:e50. https://doi.org/10.1590/s1678-9946202062050
17. Rossi F, Josey B, Sayitoglu EC, Potens R, Sultu T, Duru AD, et al. Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells. PLoS One. 2020;15(9):e0239238. Erratum in: PLoS One. 2021;16(1):e0246112. https://doi.org/10.1371/journal.pone.0239238
18. Krittanawong C, Zhang H, Sun T. Cardiovascular complications after Zika virus infection. Int J Cardiol. 2016;221:859. https://doi.org/10.1016/j.ijcard.2016.06.293
19. Strange DP, Jiyarom B, Pourhabibi Zarandi N, Xie X, Baker C, Sadri-Ardekani H, et al. Axl promotes Zika Virus entry and modulates the antiviral state of human Sertoli cells. MBio. 2019;10(4):e01372-19. https://doi.org/10.1128/mBio.01372-19
20. Lemke G. Biology of the TAM receptors. Cold Spring Harb Perspect Biol. 2013;5(11):a009076. https://doi.org/10.1101/cshperspect.a009076
21. Seferović PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(5):553-76. https://doi.org/10.1002/ejhf.1461